Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional)

The summary for the Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional): The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved contraceptive products for men and women.
Federal Grant Title: Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HD-19-004
Type of Funding: Grant
CFDA Numbers: 93.865
CFDA Descriptions: Information not provided
Current Application Deadline: April 16th, 2018
Original Application Deadline: April 16th, 2018
Posted Date: February 14th, 2018
Creation Date: February 14th, 2018
Archive Date: May 22nd, 2018
Total Program Funding: $1,500,000
Maximum Federal Grant Award: $225,000
Minimum Federal Grant Award:
Expected Number of Awards: 6
Cost Sharing or Matching: No
Last Updated: February 14th, 2018
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-004.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development...
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development...
Pediatric Critical Care and Trauma Scientist Development Program (K12 Clinical Trial Optio...
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical T...
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Wo...
Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health
Diabetes Research Centers (P30)
Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional)
Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional)
Enhancing Data Management and Sharing in NIEHS-Funded Research Grants (Admin Supp Clinical...
Understanding the Glycemic Profile of Pregnancy - Biostatistics Research Center (U01 Clini...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com